Clinical Trial Update: Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of the G-Pen glucagon injection for treating severe hypoglycemia, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia

Drugs mentioned

• G-Pen (glucagon)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hypoglycemia | Phase 2 | Status: COMPLETED | Results posted: 2016-02-03